Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Neoadjuvant chemoradiotherapy

  • You have access
    PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy
    JUNGSUP BYUN, NORA JEE-YOUNG PARK, GHILSUK YOON, MIN KYU KANG, HYE JIN KIM, SOO YEUN PARK, JUN SEOK PARK, GYU SEOG CHOI, JIN HO BAEK, JONG GWANG KIM and AN NA SEO
    Anticancer Research April 2023, 43 (4) 1513-1520; DOI: https://doi.org/10.21873/anticanres.16300
  • You have access
    Outcomes and Side Effects of Preoperative Chemoradiotherapy for Locally Advanced Upper Rectal Cancer
    SANDRA CHOMICKI, SOPHIE CHAPET, MOUSSATA DRIFA, MEHDI OUAISSI, PASCAL BOURLIER, KAMEL DEBBI, GOKOULAKRICHENANE LOGANADANE and GILLES CALAIS
    Anticancer Research October 2022, 42 (10) 4833-4840; DOI: https://doi.org/10.21873/anticanres.15988
  • You have access
    Additional Effects of Docetaxel on Neoadjuvant Radiotherapy With Cisplatin/5-Fluorouracil for Esophageal Squamous Cell Carcinoma
    KEN SASAKI, YUSUKE TSURUDA, MASATAKA SHIMONOSONO, MASAHIRO NODA, YASUTO UCHIKADO, TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, SHINICHIRO MORI, AKIHIRO NAKAJO, HIROSHI KURAHARA and TAKAO OHTSUKA
    Anticancer Research August 2022, 42 (8) 3905-3911; DOI: https://doi.org/10.21873/anticanres.15884
  • You have access
    Impact of Modern Management Strategies on the Clinical Outcome of Patients With Low Rectal Cancer – A Retrospective, Monocentric Cohort Study
    ELIAS KARAM, REMY SINDAYIGAYA, URS GIGER-PABST, MICHEL GABRIEL, NICOLAS MICHOT, LISE COURTOT, NICOLAS TABCHOURI, DRIFFA MOUSSATA, THIERRY LECOMTE, SOPHIE CHAPET, GILLES CALAIS, PASCAL BOURLIER, EPHREM SALAMÉ and MEHDI OUAISSI
    Anticancer Research April 2022, 42 (4) 1949-1963; DOI: https://doi.org/10.21873/anticanres.15673
  • You have access
    Prognostic Impact of Upfront Surgery for Locally Advanced Upper Rectal Adenocarcinoma
    OLIVIER MULLER, REMY SINDAYIGAYA, SANDRA CHOMICKI, ELIAS KARAM, NICOLAS TABCHOURI, NICOLAS MICHOT, DRIFFA MOUSSATA, THIERRY LECOMTE, SOPHIE CHAPET, GILLES CALAIS, URS GIGER-PABST, EPHREM SALAME and MEHDI OUAISSI
    Anticancer Research January 2022, 42 (1) 155-164; DOI: https://doi.org/10.21873/anticanres.15469
  • You have access
    Feasibility and Safety of Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Elderly Patients With Locally Advanced Rectal Cancer
    KYOSUKE AGAWA, TAKERU MATSUDA, KIMIHIRO YAMASHITA, HIROSHI HASEGAWA, GOSUKE TAKIGUCHI, NAOKI URAKAWA, SHINGO KANAJI, TARO OSHIKIRI, TETSU NAKAMURA, SATOSHI SUZUKI and YOSHIHIRO KAKEJI
    Anticancer Research March 2021, 41 (3) 1677-1682; DOI: https://doi.org/10.21873/anticanres.14931
  • You have access
    ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy
    GHILSUK YOON, JEE YOUNG PARK, HYE JIN KIM, GYU SEOG CHOI, JONG GWANG KIM, BYUNG WOOG KANG, MIN KYU KANG and AN NA SEO
    Anticancer Research June 2019, 39 (6) 2845-2853; DOI: https://doi.org/10.21873/anticanres.13413
  • You have access
    Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
    SHIN NISHIUMI, SEIJI FUJIGAKI, TAKASHI KOBAYASHI, TAKASHI KOJIMA, YOSHINORI ITO, HIROYUKI DAIKO, KEN KATO, HIROKAZU SHOJI, YUZO KODAMA, KAZUFUMI HONDA and MASARU YOSHIDA
    Anticancer Research January 2019, 39 (1) 519-526; DOI: https://doi.org/10.21873/anticanres.13143
  • You have access
    Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma
    YUICHIRO NAKASHIMA, HIROSHI SAEKI, QINGJIANG HU, YASUO TSUDA, YUICHI HISAMATSU, KOJI ANDO, EIJI OKI and YOSHIHIKO MAEHARA
    Anticancer Research December 2018, 38 (12) 6809-6814; DOI: https://doi.org/10.21873/anticanres.13053
  • You have access
    Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus
    TAKAOKI FURUKAWA, YOICHI HAMAI, JUN HIHARA, MANABU EMI, ICHIKO YAMAKITA, YUTA IBUKI, TOMOAKI KUROKAWA and MORIHITO OKADA
    Anticancer Research September 2018, 38 (9) 5239-5245; DOI: https://doi.org/10.21873/anticanres.12848

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire